Latest Investigational New Drug Stories
MONTREAL, Jan. 12, 2015 /PRNewswire/ - Milestone Pharmaceuticals, Inc. announced today that it received clearance of its Investigational New Drug (IND) Application from the U.S.
Biohaven filed a pre-IND meeting request with the FDA regarding lead investigational agent BHV-0223, receives written response in lieu of an in-person meeting TORONTO, Dec.
LEXINGTON, Mass., Dec.
CORALVILLE, Iowa, Dec.
CORK, Ireland, November 27, 2014 /PRNewswire/ -- Hovione announced today it has filed its first Investigational New Drug (IND) Application with the U.S.
Velos recently activated its Investigational Drug System at The University of Texas MD Anderson Cancer Center FREMONT, Calif., Nov.
-- Enrollment in Huntington's Trial Suspended Pending Further Assessment of Preclinical Data -- SEATTLE, Oct.
Provectus Biopharmaceuticals Collaborates with ERT’s COA Experts to Understand Patient Perspective during Melanoma Drug Development PHILADELPHIA, PA (PRWEB)
Speakers include Chimerix President and CEO M. Michelle Berrey, M.D., M.P.H. and Noted Ethicist Arthur L. Caplan, Ph.D. PRINCETON, N.J., Oct.
CHICAGO, Sept. 29, 2014 /PRNewswire-USNewswire/ -- Pharmacists have an important role in ensuring that clinical trials are conducted according to good clinical trials practices.